Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
2001 2
2002 2
2003 3
2004 4
2005 3
2007 2
2019 3
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
The Lived Experience of Pediatric Gene Therapy: A Scoping Review.
Kimberly L, Hunt C, Beaverson K, James E, Bateman-House A, McGowan R, DeSante-Bertkau J. Kimberly L, et al. Among authors: beaverson k. Hum Gene Ther. 2023 Dec;34(23-24):1180-1189. doi: 10.1089/hum.2023.157. Hum Gene Ther. 2023. PMID: 37964764 Review.
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management.
Jackson Y, Janssen E, Fischer R, Beaverson K, Loftus J, Betteridge K, Rhoten S, Flood E, Lundie M. Jackson Y, et al. Among authors: beaverson k. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):383-396. doi: 10.1080/14737167.2019.1612242. Epub 2019 May 9. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 31070048 Review.
Development and electronic health record validation of an algorithm for identifying patients with Duchenne muscular dystrophy in US administrative claims.
Schrader R, Posner N, Dorling P, Senerchia C, Chen Y, Beaverson K, Seare J, Garnier N, Walker V, Alvir J, Mahn M, Merla V, Zhang Y, Landis C, Buikema AR. Schrader R, et al. Among authors: beaverson k. J Manag Care Spec Pharm. 2023 Sep;29(9):1033-1044. doi: 10.18553/jmcp.2023.29.9.1033. J Manag Care Spec Pharm. 2023. PMID: 37610111 Free PMC article.
The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies.
Beaverson KL, Julkowska D, Letinturier MCV, Aartsma-Rus A, Austin J, Bueren J, Frost S, Hamamura M, Larkindale J, LaRosa G, Magenheim R, Merico A, Gerdina Pasmooij AM, Pirard V, Ekow Thomford N, Wada M, Wong-Rieger D, Hartman AL. Beaverson KL, et al. Ther Adv Rare Dis. 2023 Jul 29;4:26330040231188979. doi: 10.1177/26330040231188979. eCollection 2023 Jan-Dec. Ther Adv Rare Dis. 2023. PMID: 37529076 Free PMC article.
Patients' and caregivers' maximum acceptable risk of death for non-curative gene therapy to treat Duchenne muscular dystrophy.
Peay HL, Fischer R, Mange B, Paquin RS, Smith EC, Sadosky A, Russo L, Ricotti V, Rensch C, Morris C, Martin AS, Ganot A, Beaverson K, Mansfield C. Peay HL, et al. Among authors: beaverson k. Mol Genet Genomic Med. 2021 May;9(5):e1664. doi: 10.1002/mgg3.1664. Epub 2021 Mar 23. Mol Genet Genomic Med. 2021. PMID: 33755338 Free PMC article.
Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.
Landrum Peay H, Fischer R, Tzeng JP, Hesterlee SE, Morris C, Strong Martin A, Rensch C, Smith E, Ricotti V, Beaverson K, Wand H, Mansfield C. Landrum Peay H, et al. Among authors: beaverson k. PLoS One. 2019 May 1;14(5):e0213649. doi: 10.1371/journal.pone.0213649. eCollection 2019. PLoS One. 2019. PMID: 31042754 Free PMC article.
Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.
Paquin RS, Fischer R, Mansfield C, Mange B, Beaverson K, Ganot A, Martin AS, Morris C, Rensch C, Ricotti V, Russo LJ, Sadosky A, Smith EC, Peay HL. Paquin RS, et al. Among authors: beaverson k. Orphanet J Rare Dis. 2019 May 9;14(1):102. doi: 10.1186/s13023-019-1069-6. Orphanet J Rare Dis. 2019. PMID: 31072340 Free PMC article.
(Neonatal) retinoblastoma in the first month of life.
Abramson DH, Du TT, Beaverson KL. Abramson DH, et al. Among authors: beaverson kl. Arch Ophthalmol. 2002 Jun;120(6):738-42. doi: 10.1001/archopht.120.6.738. Arch Ophthalmol. 2002. PMID: 12049578
A phase II trial of carboplatin for intraocular retinoblastoma.
Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH. Dunkel IJ, et al. Among authors: beaverson kl. Pediatr Blood Cancer. 2007 Oct 15;49(5):643-8. doi: 10.1002/pbc.21163. Pediatr Blood Cancer. 2007. PMID: 17301956 Clinical Trial.
26 results